Literature DB >> 20414795

Examining biology and pharmacology-based hypotheses in the PLATO trial.

Richard C Becker1.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20414795     DOI： 10.1007/s11239-010-0475-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  6 in total

1.  Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.

Authors:  Z Gao; Z Li; S P Baker; R D Lasley; S Meyer; E Elzein; V Palle; J A Zablocki; B Blackburn; L Belardinelli
Journal:  J Pharmacol Exp Ther       Date:  2001-07       Impact factor: 4.030

Review 2.  Coronary microembolization: from bedside to bench and back to bedside.

Authors:  Gerd Heusch; Petra Kleinbongard; Dirk Böse; Bodo Levkau; Michael Haude; Rainer Schulz; Raimund Erbel
Journal:  Circulation       Date:  2009-11-03       Impact factor: 29.690

3.  A2A-adenosine receptor reserve for coronary vasodilation.

Authors:  J C Shryock; S Snowdy; P G Baraldi; B Cacciari; G Spalluto; A Monopoli; E Ongini; S P Baker; L Belardinelli
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

4.  Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study.

Authors:  Frank Breuckmann; Kai Nassenstein; Christina Bucher; Ina Konietzka; Gernot Kaiser; Thomas Konorza; Christoph Naber; Andreas Skyschally; Petra Gres; Gerd Heusch; Raimund Erbel; Jörg Barkhausen
Journal:  JACC Cardiovasc Imaging       Date:  2009-02

5.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes.

Authors:  Lars Wallentin; Richard C Becker; Andrzej Budaj; Christopher P Cannon; Håkan Emanuelsson; Claes Held; Jay Horrow; Steen Husted; Stefan James; Hugo Katus; Kenneth W Mahaffey; Benjamin M Scirica; Allan Skene; Philippe Gabriel Steg; Robert F Storey; Robert A Harrington; Anneli Freij; Mona Thorsén
Journal:  N Engl J Med       Date:  2009-08-30       Impact factor: 91.245

6.  Comparison of ticagrelor and thienopyridine P2Y(12) binding characteristics and antithrombotic and bleeding effects in rat and dog models of thrombosis/hemostasis.

Authors:  J J J van Giezen; Pia Berntsson; Helen Zachrisson; Jan-Arne Björkman
Journal:  Thromb Res       Date:  2009-08-18       Impact factor: 3.944
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.